TGM2 and chronic myelogenous leukemia, BCR-ABL1 positive: The results presented in Figure 5B showed that inhibition of TG2 activity in the presence of R283 reduced the percentage of apoptotic cells, corroborating the role of TG2 in triggering apoptosis in CML cells.